Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : Clinical Pharmacist, 2010

Sort by: Newest first Oldest first A-Z Z-A

  • Dasatinib and nilotinib useful alternatives for CML

    15 JUL 2010 6:05

    Dasatinib and nilotinib could be useful alternatives to imatinib for first-line treatment of certain patients with chronic myeloid leukaemia (CML), according to two studies published in the New England Journal of Medicine.

  • Combination of co-trimoxazole and renin/angiotensin drugs linked with hyperkalaemia

    15 JUL 2010 6:02

    Combining co-trimoxazole with ACE inhibitors or angiotensin-II receptor blockers (ARBs) is associated with an increased risk of hyperkalaemia-related hospital admission among older patients (Archives of Internal Medicine 2010;170:1045).

  • Rheumatoid arthritis (answers) Subscription

    14 JUL 2010

    QuestionsMay 2010’s Lifelong Learning questions are based on the CLINICALFOCUS articles on Rheumatoid arthritisThe questions can be viewed/printedThis online module is closed

  • Money keyboard

    Trends in NHS funding: individual funding requests Subscription

    14 JUL 2010 11:43

    You have a patient who you believe will benefit from a medicine that is not routinely funded by their primary care trust. Here we look at how such individual funding requests can be handled by hospitals

  • Rosiglitazone safety dilemma unclarified by new data

    13 JUL 2010 15:02

    Uncertainty around the cardiovascular safety of rosiglitazone for patients with type 2 diabetes continues with the recent publication of new data on the matter.

  • UK Clinical Pharmacy Association (July 2010 news) Subscription

    13 JUL 2010 13:00

    See UKCPATopics includeNew Chair for UKCPAGroup newsHow local practice forums can support researchNew antiplatelet medicine cardUpdate on pharmacy regulationGeneral secretary sets new plans rollingStudy daysMembership 

  • Vitamin A analogues do not raise fracture risk

    3 JUN 2010 15:34

    Large doses of systemic vitamin A analogues are not associated with an increased risk of fracture, a study has shown (Archives of Dermatology 2010;146:478).

  • The magic of marketing (Clinical Pharmacist, June 2010) Subscription

    3 JUN 2010 15:33

    Nothing can get your message out there like a good marketing campaign. Plenty of products and services come to mind that people simply wouldn’t know a thing about if it weren’t for their successful promotion — comparethemeerkat.com, 118118, the new (old) Wispa, to name a few.

  • Sarah Carter

    Common goals and a common vision Subscription

    3 JUN 2010 15:32

    By working together, pharmacists can avoid duplication of work, celebrate leadership and disseminate excellence and best practice

  • Industry-funded trials shown to be biased

    3 JUN 2010 15:31

    Clinical trials funded by pharmaceutical companies are more likely to be biased, a systematic review has shown (Deutsches Ärzteblatt International 2010;107:279, ibid p295).

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.